<DOC>
	<DOCNO>NCT01679483</DOCNO>
	<brief_summary>To compare incidence lymphocele lymphatic ascites patient use versus use FloSeal lymph node dissection</brief_summary>
	<brief_title>Efficacy Study FloSeal Prevention Lymphocele After Lymphadenectomy Gynecologic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Lymphocele</mesh_term>
	<criteria>Histologically confirm primary cancer uterine cervix , uterine corpus , ovary , fallopian tube FIGO stage Cervical cancer : FIOG stage IA2IIA2 Uterine cancer : FIGO stage IIII Ovarian fallopian tubal cancer : FIGO stage IIIIB Patients undergoing surgery include pelvic and/or paraaortic lymph node dissection Patients adequate bone marrow , renal hepatic function : WBC &gt; 3,000 cells/mcl Platelets &gt; 100,000/mcl Creatinine &lt; 2.0 mg/dL Bilirubin &lt; 1.5 x normal SGOT SGPT &lt; 3 x normal American Society Anesthesiology Physical Status 01 Performance status ECOG 02 Patient must suitable candidate surgery Patients sign approve Informed Consent Patients history pelvic abdominal radiotherapy ; Patients pregnant Patients contraindication surgery ; Patients unfit Surgery : serious concomitant systemic disorder incompatible study ( discretion investigator ) ; Patient 's compliance geographic proximity allow adequate followup . Patients undergo lymph node sample</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>